Dr. Manish Srivastav

MBBS (2003): Government Medical College, Tirunelveli, Tamil Nadu.
MD MEDICINE (2011): Rajendra Inst. of Medical Sciences, Ranchi.
DM ENDOCRINOLOGY (2017): Lala Lajpat Rai Medical College and SVBP Hospital, Meerut.

Consultant Endocrinologist at Narayana Healthcare/Hirodalaya, Gurgaon (May 2023 to present).
Consultant Endocrinologist at Regency Healthcare, Kanpur (July 2021-Dec 2022).
Teaching faculty CCEBDM-certificate course, 2021-2022, Kanpur.
Organizing-Secretary (past) Kanpur Diabetes Association., Kanpur
Researcher for various regional diabetic and thyroid disorder studies in Western U.P.
Clinical Investigator for regional trials on diabetes and the effect of Dapagliflozin on the metabolic profile of type 2 diabetic patients.
National Speaker for APICON.2015 on the management of peripheral neuropathy in diabetic patients.
Speaker at ESICON 2018, about the effect of various insulin regimens on different subsets of patients with type 2 diabetes mellitus.

Management practices and advances in the treatment of primary aldosteronism" - Indian Journal of Endocrinology and Metabolism 2017-224-33.
Thyroid symptomatology across the spectrum of hyperthyroidism and impact of levothyroxine supplementation in patients with Hashimoto's Thyroiditis" - Indian Journal of Endocrinology and Metabolism 2018; 22(4): 526-532.
Clinical profile of patients with gout presenting to a tertiary care hospital" - Indian Journal of Rheumatology 2018; 13(2): 109-113.
Comparison of efficacy and safety of insulin degludec and insulin glargine in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials" - Indian Journal of Endocrinology and Metabolism 2018; 22(6): 796-803.